Acrivon Therapeutics, Common Stock Price History
| ACRV Stock | 5.61 0.25 4.66% |
If you're considering investing in Acrivon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acrivon Therapeutics, stands at 5.61, as last reported on the 24th of March, with the highest price reaching 5.65 and the lowest price hitting 5.25 during the day. Acrivon Therapeutics, secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Acrivon Therapeutics, Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acrivon Therapeutics,'s Risk Adjusted Performance of (0.03), standard deviation of 5.61, and Mean Deviation of 4.13 to double-check the risk estimate we provide.
At this time, Acrivon Therapeutics,'s Other Stockholder Equity is fairly stable compared to the past year. Capital Stock is likely to climb to about 27.8 K in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 23.6 M in 2025. . At this time, Acrivon Therapeutics,'s Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 0.85 in 2025, whereas Price Earnings To Growth Ratio is likely to drop (0.02) in 2025. Acrivon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acrivon |
Sharpe Ratio = -0.0087
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACRV |
Estimated Market Risk
| 5.71 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Acrivon Therapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acrivon Therapeutics, by adding Acrivon Therapeutics, to a well-diversified portfolio.
Acrivon Therapeutics, Stock Price History Chart
There are several ways to analyze Acrivon Stock price data. The simplest method is using a basic Acrivon candlestick price chart, which shows Acrivon Therapeutics, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 5, 2025 | 6.97 |
| Lowest Price | February 11, 2025 | 4.91 |
Acrivon Therapeutics, March 24, 2025 Stock Price Synopsis
Various analyses of Acrivon Therapeutics,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Acrivon Stock. It can be used to describe the percentage change in the price of Acrivon Therapeutics, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Acrivon Stock.| Acrivon Therapeutics, Accumulation Distribution | 2,815 | |
| Acrivon Therapeutics, Price Daily Balance Of Power | 0.62 | |
| Acrivon Therapeutics, Price Action Indicator | 0.29 | |
| Acrivon Therapeutics, Price Rate Of Daily Change | 1.05 |
Acrivon Therapeutics, March 24, 2025 Stock Price Analysis
Acrivon Stock Price History Data
The price series of Acrivon Therapeutics, for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 2.3 with a coefficient of variation of 9.45. The prices are distributed with arithmetic mean of 5.76. The median price for the last 90 days is 5.55.| Open | High | Low | Close | Volume | ||
| 03/24/2025 | 5.52 | 5.65 | 5.25 | 5.61 | 39,756 | |
| 03/24/2025 | 5.52 | 5.65 | 5.25 | 5.61 | 39,756 | |
| 03/21/2025 | 5.06 | 5.40 | 5.00 | 5.36 | 64,738 | |
| 03/20/2025 | 5.47 | 5.52 | 5.14 | 5.14 | 14,471 | |
| 03/19/2025 | 5.41 | 5.62 | 5.20 | 5.46 | 21,762 | |
| 03/18/2025 | 5.33 | 5.42 | 5.29 | 5.36 | 15,296 | |
| 03/17/2025 | 5.52 | 5.57 | 5.32 | 5.50 | 16,522 | |
| 03/14/2025 | 5.19 | 5.46 | 5.19 | 5.44 | 17,905 | |
| 03/13/2025 | 5.31 | 5.36 | 5.07 | 5.07 | 13,743 | |
| 03/12/2025 | 5.20 | 5.39 | 5.16 | 5.33 | 18,510 | |
| 03/11/2025 | 5.38 | 5.54 | 5.21 | 5.45 | 18,444 | |
| 03/10/2025 | 5.28 | 5.45 | 5.18 | 5.29 | 23,839 | |
| 03/07/2025 | 5.58 | 5.58 | 5.31 | 5.54 | 11,979 | |
| 03/06/2025 | 5.68 | 5.68 | 5.29 | 5.51 | 19,379 | |
| 03/05/2025 | 5.49 | 5.75 | 5.33 | 5.58 | 31,416 | |
| 03/04/2025 | 5.19 | 5.55 | 5.14 | 5.36 | 55,202 | |
| 03/03/2025 | 5.54 | 5.54 | 5.07 | 5.14 | 32,486 | |
| 02/28/2025 | 5.34 | 5.59 | 5.25 | 5.31 | 21,356 | |
| 02/27/2025 | 5.41 | 5.68 | 5.27 | 5.34 | 20,271 | |
| 02/26/2025 | 5.53 | 5.65 | 5.31 | 5.31 | 17,599 | |
| 02/25/2025 | 5.40 | 5.68 | 5.31 | 5.53 | 41,190 | |
| 02/24/2025 | 5.58 | 5.96 | 5.28 | 5.38 | 255,095 | |
| 02/21/2025 | 5.94 | 5.94 | 5.54 | 5.54 | 40,699 | |
| 02/20/2025 | 5.35 | 6.08 | 5.35 | 5.85 | 52,908 | |
| 02/19/2025 | 5.26 | 5.36 | 5.00 | 5.31 | 23,300 | |
| 02/18/2025 | 5.53 | 5.68 | 5.12 | 5.26 | 29,710 | |
| 02/14/2025 | 5.42 | 5.73 | 5.31 | 5.42 | 19,722 | |
| 02/13/2025 | 5.20 | 5.37 | 5.05 | 5.36 | 16,113 | |
| 02/12/2025 | 4.91 | 5.16 | 4.91 | 5.16 | 35,103 | |
| 02/11/2025 | 5.49 | 5.49 | 4.69 | 4.91 | 79,290 | |
| 02/10/2025 | 6.12 | 6.12 | 5.58 | 5.62 | 26,302 | |
| 02/07/2025 | 6.44 | 6.59 | 6.02 | 6.02 | 31,865 | |
| 02/06/2025 | 6.77 | 7.24 | 6.36 | 6.51 | 66,689 | |
| 02/05/2025 | 5.83 | 8.00 | 5.83 | 6.97 | 738,524 | |
| 02/04/2025 | 5.67 | 5.91 | 5.56 | 5.91 | 23,538 | |
| 02/03/2025 | 6.07 | 6.07 | 5.46 | 5.57 | 28,444 | |
| 01/31/2025 | 5.94 | 6.28 | 5.88 | 6.07 | 27,720 | |
| 01/30/2025 | 5.46 | 5.89 | 5.46 | 5.79 | 12,912 | |
| 01/29/2025 | 5.50 | 5.83 | 5.45 | 5.55 | 14,918 | |
| 01/28/2025 | 5.59 | 5.60 | 5.28 | 5.55 | 74,945 | |
| 01/27/2025 | 5.45 | 5.76 | 5.45 | 5.56 | 26,533 | |
| 01/24/2025 | 5.68 | 5.85 | 5.44 | 5.45 | 15,213 | |
| 01/23/2025 | 5.62 | 5.70 | 5.48 | 5.69 | 20,717 | |
| 01/22/2025 | 5.81 | 5.81 | 5.39 | 5.60 | 19,618 | |
| 01/21/2025 | 5.80 | 5.88 | 5.65 | 5.65 | 24,816 | |
| 01/17/2025 | 5.60 | 5.88 | 5.41 | 5.78 | 79,500 | |
| 01/16/2025 | 5.53 | 5.66 | 5.36 | 5.55 | 43,274 | |
| 01/15/2025 | 5.78 | 6.00 | 5.41 | 5.54 | 51,696 | |
| 01/14/2025 | 5.60 | 5.60 | 5.35 | 5.56 | 28,951 | |
| 01/13/2025 | 5.46 | 5.56 | 5.32 | 5.51 | 33,187 | |
| 01/10/2025 | 5.95 | 6.00 | 5.45 | 5.47 | 41,944 | |
| 01/08/2025 | 5.76 | 6.34 | 5.76 | 6.10 | 24,470 | |
| 01/07/2025 | 6.63 | 6.84 | 6.26 | 6.30 | 30,999 | |
| 01/06/2025 | 6.70 | 7.18 | 6.48 | 6.79 | 45,300 | |
| 01/03/2025 | 5.75 | 6.70 | 5.75 | 6.62 | 69,983 | |
| 01/02/2025 | 6.21 | 6.40 | 5.68 | 5.69 | 46,173 | |
| 12/31/2024 | 5.50 | 6.15 | 5.50 | 6.02 | 36,577 | |
| 12/30/2024 | 5.87 | 5.87 | 5.40 | 5.41 | 72,462 | |
| 12/27/2024 | 6.29 | 6.39 | 5.81 | 5.92 | 28,063 | |
| 12/26/2024 | 6.23 | 6.32 | 6.13 | 6.19 | 26,616 | |
| 12/24/2024 | 6.25 | 6.26 | 6.01 | 6.23 | 27,447 |
About Acrivon Therapeutics, Stock history
Acrivon Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acrivon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acrivon Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acrivon Therapeutics, stock prices may prove useful in developing a viable investing in Acrivon Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.4 M | 23.6 M | |
| Net Loss | -28.1 M | -29.5 M |
Acrivon Therapeutics, Quarterly Net Working Capital |
|
Acrivon Therapeutics, Stock Technical Analysis
Acrivon Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Acrivon Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acrivon Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Acrivon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acrivon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | 0.151 | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Acrivon Stock Analysis
When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.